van Thuijl Hinke F, Scheinin Ilari, Sie Daoud, Alentorn Agusti, van Essen Hendrik F, Cordes Martijn, Fleischeuer Ruth, Gijtenbeek Anja M, Beute Guus, van den Brink Wimar A, Meijer Gerrit A, Havenith Miek, Idbaih Ahmed, Hoang-Xuan Khê, Mokhtari Karima, Verhaak Roel Gw, van der Valk Paul, van de Wiel Mark A, Heimans Jan J, Aronica Eleonora, Reijneveld Jaap C, Wesseling Pieter, Ylstra Bauke
Genome Biol. 2014 Sep 23;15(9):471. doi: 10.1186/s13059-014-0471-6.
The disease course of patients with diffuse low-grade glioma is notoriously unpredictable. Temporal and spatially distinct samples may provide insight into the evolution of clinically relevant copy number aberrations (CNAs). The purpose of this study is to identify CNAs that are indicative of aggressive tumor behavior and can thereby complement the prognostically favorable 1p/19q co-deletion.
Genome-wide, 50 base pair single-end sequencing was performed to detect CNAs in a clinically well-characterized cohort of 98 formalin-fixed paraffin-embedded low-grade gliomas. CNAs are correlated with overall survival as an endpoint. Seventy-five additional samples from spatially distinct regions and paired recurrent tumors of the discovery cohort were analyzed to interrogate the intratumoral heterogeneity and spatial evolution. Loss of 10q25.2-qter is a frequent subclonal event and significantly correlates with an unfavorable prognosis. A significant correlation is furthermore observed in a validation set of 126 and confirmation set of 184 patients. Loss of 10q25.2-qter arises in a longitudinal manner in paired recurrent tumor specimens, whereas the prognostically favorable 1p/19q co-deletion is the only CNA that is stable across spatial regions and recurrent tumors.
CNAs in low-grade gliomas display extensive intratumoral heterogeneity. Distal loss of 10q is a late onset event and a marker for reduced overall survival in low-grade glioma patients. Intratumoral heterogeneity and higher frequencies of distal 10q loss in recurrences suggest this event is involved in outgrowth to the recurrent tumor.
弥漫性低级别胶质瘤患者的病程 notoriously 难以预测。时间和空间上不同的样本可能有助于深入了解临床相关拷贝数变异(CNA)的演变。本研究的目的是识别指示侵袭性肿瘤行为的CNA,从而补充预后良好的1p/19q共缺失。
对98例福尔马林固定石蜡包埋的低级别胶质瘤的临床特征明确的队列进行全基因组50碱基对单端测序以检测CNA。以总生存作为终点,CNA与之相关。分析了来自发现队列中空间不同区域的另外75个样本以及配对的复发性肿瘤,以研究肿瘤内异质性和空间演变。10q25.2-qter缺失是常见的亚克隆事件,与不良预后显著相关。在126例患者的验证集和184例患者的确认集中也观察到显著相关性。10q25.2-qter缺失在配对的复发性肿瘤标本中呈纵向出现,而预后良好的1p/19q共缺失是唯一在空间区域和复发性肿瘤中均稳定的CNA。
低级别胶质瘤中的CNA表现出广泛的肿瘤内异质性。10q远端缺失是晚期事件,是低级别胶质瘤患者总生存降低的标志物。肿瘤内异质性以及复发中10q远端缺失的较高频率表明该事件参与了复发性肿瘤的生长。